Howland Capital Management LLC Eli Lilly & CO Transaction History

Howland Capital Management LLC

$2.26 Billion
Q3 2024

A detailed history of Howland Capital Management LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Howland Capital Management LLC holds 3,839 shares of LLY stock, worth $3.05 Million. This represents 0.15% of its overall portfolio holdings.

Number of Shares

3,839

Previous 4,532 15.29%

Holding current value

$3.05 Million

Previous $4.1 Million 17.11%

% of portfolio

0.15%

Previous 0.2%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$772.14 - $960.02 $535,093 - $665,293	-693 Reduced 15.29%	3,839 $3.4 Million
Q2 2024 Aug 12, 2024	SELL	$724.87 - $909.04 $56,539 - $70,905	-78 Reduced 1.69%	4,532 $4.1 Million
Q1 2024 May 03, 2024	SELL	$592.2 - $792.28 $149,234 - $199,654	-252 Reduced 5.18%	4,610 $3.59 Million
Q4 2023 Jan 23, 2024	SELL	$525.19 - $619.13 $245,788 - $289,752	-468 Reduced 8.78%	4,862 $2.83 Million
Q3 2023 Oct 17, 2023	SELL	$434.7 - $599.3 $215,176 - $296,653	-495 Reduced 8.5%	5,330 $2.86 Million
Q2 2023 Jul 28, 2023	BUY	$350.74 - $468.98 $1,753 - $2,344	5 Added 0.09%	5,825 $2.73 Million
Q1 2023 May 05, 2023	SELL	$310.63 - $364.82 $244,465 - $287,113	-787 Reduced 11.91%	5,820 $2 Million
Q4 2022 Jan 30, 2023	SELL	$321.55 - $374.67 $107,076 - $124,765	-333 Reduced 4.8%	6,607 $2.42 Million
Q3 2022 Oct 17, 2022	BUY	$296.48 - $337.87 $311,007 - $354,425	1,049 Added 17.81%	6,940 $2.24 Million
Q2 2022 Jul 22, 2022	BUY	$278.73 - $327.27 $391,058 - $459,159	1,403 Added 31.26%	5,891 $1.91 Million
Q1 2022 Apr 27, 2022	BUY	$234.69 - $291.66 $39,897 - $49,582	170 Added 3.94%	4,488 $1.29 Million
Q4 2021 Jan 26, 2022	BUY	$224.85 - $279.04 $5,621 - $6,976	25 Added 0.58%	4,318 $1.19 Million
Q1 2021 Apr 28, 2021	BUY	$164.32 - $212.72 $37,793 - $48,925	230 Added 5.66%	4,293 $802,000
Q4 2020 Jan 26, 2021	SELL	$130.46 - $172.63 $17,220 - $22,787	-132 Reduced 3.15%	4,063 $686,000
Q3 2020 Oct 26, 2020	SELL	$146.22 - $169.13 $4,386 - $5,073	-30 Reduced 0.71%	4,195 $621,000
Q1 2020 Apr 13, 2020	SELL	$119.05 - $147.35 $32,619 - $40,373	-274 Reduced 6.09%	4,225 $586,000
Q4 2019 Jan 23, 2020	SELL	$106.92 - $132.43 $12,295 - $15,229	-115 Reduced 2.49%	4,499 $591,000
Q3 2019 Oct 22, 2019	BUY	$106.79 - $116.16 $86,179 - $93,741	807 Added 21.2%	4,614 $516,000
Q2 2019 Jul 17, 2019	SELL	$110.79 - $129.32 $99,711 - $116,388	-900 Reduced 19.12%	3,807 $422,000
Q1 2019 Apr 22, 2019	SELL	$111.31 - $131.02 $52,872 - $62,234	-475 Reduced 9.17%	4,707 $611,000
Q4 2018 Jan 23, 2019	BUY	$105.9 - $118.64 $12,072 - $13,524	114 Added 2.25%	5,182 $600,000
Q3 2018 Oct 25, 2018	SELL	$85.86 - $107.31 $10,389 - $12,984	-121 Reduced 2.33%	5,068 $544,000
Q1 2018 May 02, 2018	BUY	$74.21 - $87.6 $14,619 - $17,257	197 Added 3.95%	5,189 $401,000
Q3 2017 Oct 30, 2017	BUY	$77.07 - $85.54 $384,733 - $427,015	4,992	4,992 $427,000

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $756B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Howland Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Howland Capital Management LLC with notifications on news.

Account

Howland Capital Management LLC Eli Lilly & CO Transaction History